Hunter Perkins Capital Management’s Voyager Therapeutics VYGR Stock Holding History

Hunter Perkins Capital Management’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$73K	Hold	20,965	–	–	0.02%	148
2026 Q1	$81K	Hold	20,965	–	–	0.02%	141
2025 Q4	$82K	Sell	20,965 -32,875	-61%	-$145K	0.02%	114
2025 Q3	$251K	Sell	53,840 -6,500	-11%	-$23.5K	0.06%	111
2025 Q2	$188K	Hold	60,340	–	–	0.04%	107
2025 Q1	$204K	Sell	60,340 -2,700	-4%	-$12.6K	0.05%	100
2024 Q4	$357K	Sell	63,040 -1,000	-2%	-$6.45K	0.07%	95
2024 Q3	$375K	Buy	64,040 +2,025	+3%	+$14.7K	0.08%	98
2024 Q2	$491K	Sell	62,015 -3,150	-5%	-$26.4K	0.1%	94
2024 Q1	$607K	Buy	+65,165	New	+$550K	0.12%	85

Other funds holding VYGR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Hunter Perkins Capital Management's VYGR Position: Q2 2026 in Review

Hunter Perkins Capital Management held its Voyager Therapeutics (VYGR) position steady in Q2 2026 at 20,965 shares worth $73K. The position accounts for 0.02% of the portfolio, ranked #148.

Hunter Perkins Capital Management first reported a position in VYGR in Q1 2024 and has held it in 10 quarters since. The position peaked at $607K in Q1 2024. 135 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

Hunter Perkins Capital Management held 20,965 shares of Voyager Therapeutics worth $73K as of Q2 2026.
Hunter Perkins Capital Management left its Voyager Therapeutics share count unchanged in Q2 2026.
Voyager Therapeutics made up 0.02% of Hunter Perkins Capital Management's portfolio in Q2 2026, its #148 holding.
Hunter Perkins Capital Management first reported a position in Voyager Therapeutics in Q1 2024 and has held it in 10 quarters since.
Hunter Perkins Capital Management's Voyager Therapeutics position peaked at $607K in Q1 2024.
135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Hunter Perkins Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.